VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
- Status
- RECRUITING
- Phase
- N/A
Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
- Status
- RECRUITING
- Phase
- PHASE1
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- NA
Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Selinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Massage Impact on Sleep in Pediatric Oncology
- Status
- RECRUITING
- Phase
- NA
Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients
- Status
- RECRUITING
- Phase
- NA
A Clinical Study to Evaluate the Safety and Efficacy of CLL1 and CD38 Dual-Target CAR-T Cell Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1